Vivos (RDGL) Cash from Operations Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.10% |
| Sep 30, 2025 | -20.04% |
| Jun 30, 2025 | -20.39% |
| Mar 31, 2025 | -39.15% |
| Dec 31, 2024 | -13.22% |
| Sep 30, 2024 | -22.31% |
| Jun 30, 2024 | -22.80% |
| Mar 31, 2024 | -5.28% |
| Dec 31, 2023 | 2.76% |
| Sep 30, 2023 | -25.62% |
| Jun 30, 2023 | -45.28% |
| Mar 31, 2023 | -43.47% |
| Dec 31, 2022 | -11.45% |
| Sep 30, 2022 | 4.02% |
| Jun 30, 2022 | 19.34% |
| Mar 31, 2022 | -6.87% |
| Dec 31, 2021 | 41.95% |
| Sep 30, 2021 | -15.52% |
| Jun 30, 2021 | 17.58% |
| Mar 31, 2021 | 18.73% |
| Dec 31, 2020 | 6.67% |
| Sep 30, 2020 | -6.89% |
| Jun 30, 2020 | 3.23% |
| Mar 31, 2020 | 19.82% |
| Dec 31, 2019 | 6.01% |
| Sep 30, 2019 | -43.66% |
| Jun 30, 2019 | 17.49% |
| Mar 31, 2019 | 8.67% |
| Dec 31, 2018 | -25.38% |
| Sep 30, 2018 | 28.10% |
| Jun 30, 2018 | 44.88% |
| Mar 31, 2018 | 38.32% |
| Dec 31, 2017 | 14.15% |
| Sep 30, 2017 | 11.84% |
| Jun 30, 2017 | 0.56% |
| Mar 31, 2017 | 0.33% |
| Dec 31, 2016 | -66.27% |
| Sep 30, 2016 | 75.05% |
| Jun 30, 2016 | -33.72% |
| Mar 31, 2016 | -31.21% |
| Dec 31, 2015 | 20.54% |
| Sep 30, 2015 | 16.34% |